Boomerang Ventures

Founded in 2019 by Matthew Williams, Boomerang Ventures is an Indianapolis, Indiana-based venture capital firm and operational studio that invests in early-stage connected health technology and life sciences companies. Led by Williams and partners Audrey Beckman, David Helmer, and Eric Beier, the organization operates a hybrid model combining a dedicated 2022 venture fund with a 2020 studio to guide entrepreneurs through commercialization. Demonstrating its investment capacity, the firm led a $1.7 million Series Seed funding round in December 2023 for Xploro Inc., a pediatric digital health platform. To source healthcare innovations, Boomerang collaborates with academic institutions, maintaining established relationships with Indiana University and Purdue University alongside partnership discussions with Notre Dame. Operationally, the studio has already founded one new company while actively managing several healthcare projects and maintaining a pipeline of more than 20 prospective ventures.

High-Level Overview

Boomerang Ventures is a venture studio and investment fund focused on transforming healthcare through technology, particularly in connected health tech and health innovation. Their mission is to partner with founders, investors, and institutions to accelerate the development and commercialization of novel healthcare technologies that improve patient outcomes and disrupt traditional healthcare models. They invest primarily in early-growth health tech startups, providing not only capital but also operational support through their venture studio model. Their portfolio includes companies developing digital therapeutics, patient education platforms, and cost-reducing healthcare solutions, reflecting a strong emphasis on leveraging technology to address clinical and systemic healthcare challenges[1][2][3].

Origin Story

Founded in 2019 and based in Indianapolis, Indiana, Boomerang Ventures was established by a team of partners including Ariel MacTavish, Audrey Beckman, David Helmer, and Eric Beier, who bring expertise in innovation, medical practice, and venture investing. The firm evolved to combine a venture capital fund with a venture studio, enabling them to co-create and accelerate startups alongside investing. This hybrid model allows them to engage deeply with founders and strategic partners to bring healthcare innovations to market faster. Their focus has consistently been on healthtech and medtech sectors, reflecting a commitment to improving healthcare delivery and outcomes through technology[4][5][6].

Core Differentiators

• Unique Investment Model: Combines venture capital funding with an operational venture studio that collaborates closely with startups to refine product-market fit and scale innovations.
• Network Strength: Leverages a curated network of investors, healthcare institutions, and strategic partners to provide portfolio companies with access to resources beyond capital.
• Track Record: Focused investments in early-stage connected health tech companies with promising clinical and commercial potential.
• Operating Support: Provides hands-on support in technology assessment, product design, and market strategy, exemplified by team members with engineering and bioengineering expertise who work directly with startups[1][6].

Role in the Broader Tech Landscape

Boomerang Ventures rides the growing trend of digital health and connected healthcare technologies, which are increasingly critical due to rising healthcare costs, demand for patient-centric care, and advances in digital therapeutics and remote monitoring. The timing is favorable as healthcare systems seek scalable, technology-driven solutions to improve outcomes and reduce costs. By fostering innovation in areas like digital pain management, patient education, and musculoskeletal care, Boomerang Ventures influences the broader ecosystem by accelerating adoption of disruptive health technologies and supporting startups that address unmet clinical needs[1][3][4].

Quick Take & Future Outlook

Looking ahead, Boomerang Ventures is well-positioned to expand its influence as healthcare continues to embrace digital transformation. Trends such as personalized medicine, virtual care, and AI-driven diagnostics will likely shape their investment focus. Their hybrid studio-fund model offers a competitive advantage in nurturing startups through early stages to commercialization. As healthcare innovation accelerates, Boomerang Ventures’ role in bridging technology and clinical application will be increasingly vital, potentially making them a key player in shaping the future of healthtech innovation[1][5].